Evidence map›Paper›PMID 32096305›Full record

ArticleEMBO reports2020

Human RAP1 specifically protects telomeres of senescent cells from DNA damage.

Liudmyla Lototska, Jia-Xing Yue, Jing Li, Marie-Josèphe Giraud-Panis, Zhou Songyang, Nicola J Royle, Gianni Liti, Jing Ye, Eric Gilson, Aaron Mendez-Bermudez

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Telomere Crisis Shapes Cancer Evolution.Cold Spring Harbor perspectives in biology · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Molecular mechanisms of aging and anti-aging strategies.Cell communication and signaling : CCS · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Biomarkers of aging.Science China. Life sciences · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Liudmyla LototskaShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Université Côte d'Azur, CNRS, Inserm, International Research Laboratory in Hematology, Cancer and Aging, State Key Laboratory of Medical Genomics, Shanghai, China.
Jia-Xing YueUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Medical School of Nice, Nice, France.
Jing LiUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Medical School of Nice, Nice, France.
Marie-Josèphe Giraud-PanisUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Medical School of Nice, Nice, France.
Zhou SongyangVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.
Nicola J RoyleDepartment of Genetics, University of Leicester, Leicester, UK.ORCID 0000-0003-1174-6329
Gianni LitiUniversité Côte d'Azur, CNRS, INSERM, IRCAN, Medical School of Nice, Nice, France.
Jing YeShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Université Côte d'Azur, CNRS, Inserm, International Research Laboratory in Hematology, Cancer and Aging, State Key Laboratory of Medical Genomics, Shanghai, China.ORCID 0000-0002-9471-3321
Eric GilsonShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Université Côte d'Azur, CNRS, Inserm, International Research Laboratory in Hematology, Cancer and Aging, State Key Laboratory of Medical Genomics, Shanghai, China.ORCID 0000-0001-5738-6723
Aaron Mendez-BermudezShanghai Ruijin Hospital, Shanghai Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Université Côte d'Azur, CNRS, Inserm, International Research Laboratory in Hematology, Cancer and Aging, State Key Laboratory of Medical Genomics, Shanghai, China.ORCID 0000-0002-0768-4340
Centre National de la Recherche Scientifique · FRShanghai Jiao Tong University · CNSun Yat-sen University · CNUniversity of Leicester · GB

Funding

Agence Nationale de la Recherche (ANR) (program TELOCHROM) ANR-19-CE12-0020-01Fondation ARC ("Programme Labellisé")Fondation pour la Recherche Médicale FRM FDT20170437327Foundation of Shanghai Jiaotong University School of Medicine for Translational Medicine Innovation Project 15ZH4005Institut Nationale du Cancer (INCa) (program REPLITOP)LABEX SIGNALIFE ANR-11-LABX-0028-01Medical Research Council G0500336National Natural Science Foundation of China 81522017National Natural Science Foundation of China 81971312National Natural Science Foundation of China 91749126Shanghai Municipal Science and Technology Commission 19XD1422500
6 · The paper itself

Abstract

Repressor/activator protein 1 (RAP1) is a highly evolutionarily conserved protein found at telomeres. Although yeast Rap1 is a key telomere capping protein preventing non-homologous end joining (NHEJ) and consequently telomere fusions, its role at mammalian telomeres in vivo is still controversial. Here, we demonstrate that RAP1 is required to protect telomeres in replicative senescent human cells. Downregulation of RAP1 in these cells, but not in young or dividing pre-senescent cells, leads to telomere uncapping and fusions. The anti-fusion effect of RAP1 was further explored in a HeLa cell line where RAP1 expression was depleted through an inducible CRISPR/Cas9 strategy. Depletion of RAP1 in these cells gives rise to telomere fusions only when telomerase is inhibited. We further show that the fusions triggered by RAP1 loss are dependent upon DNA ligase IV. We conclude that human RAP1 is specifically involved in protecting critically short telomeres. This has important implications for the functions of telomeres in senescent cells.

Indexed as

TelomereTranscription Factor AP-1AnimalsCellular SenescenceDNA DamageHeLa CellsHumansTelomere-Binding ProteinsTelomere-Binding ProteinsTranscription Factor AP-1chromosome fusionsnon-homologous end joiningRAP1replicative senescencetelomeres

Identifiers

PMID32096305
PMCPMC7132343
OpenAlexW3008684620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.